For instance, previous studies showing metabolic dysfunction in Brn-3b KO mutants (hyperglycaemia, insulin resistance and increased visceral WAT deposits [26, 30, 35]), means that deregulation of metabolic genes in Brn-3b KO aortas was unsurprising. This evidence concerns the gene POU4F2 and Hyperglycemia.